Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Guidance for fluorescence in situ hybridization testing in hematologic disorders.
Seizure interference by medications: how big a problem?
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Guidance for fluorescence in situ hybridization testing in hematologic disorders.
Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007 Apr; 9(2):134-43.
View in:
PubMed
subject areas
Cell Nucleus
Chromosome Banding
Genetic Testing
Hematologic Diseases
Humans
In Situ Hybridization, Fluorescence
Interphase
Molecular Probes
authors with profiles
Daynna J. Wolff